Physiologic mechanisms of therapeutic resistance: Blood flow and hypoxia

Hematology/Oncology Clinics of North America

Volumn 9, Issue 2, 1995, Pages 475-506

  Teicher, B A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ANGIOTENSIN; BLEOMYCIN; CALCIUM CHANNEL BLOCKING AGENT; CARBOGEN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; FLUNARIZINE; FLUOSOL; HEMOGLOBIN; HYDRALAZINE; MELPHALAN; NICOTINAMIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NITROSOUREA DERIVATIVE; OXYGEN; PENTOXIFYLLINE; PERFLUORO COMPOUND; PERFLUOROOCTYL BROMIDE; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL HYPOXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG MECHANISM; FIBROSARCOMA; HEAD AND NECK CANCER; HUMAN; HYPERBARIC OXYGEN; HYPERTHERMIC THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; TUMOR VASCULARIZATION; UTERINE CERVIX CARCINOMA;

EID: 0028964971     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0889-8588(18)30105-9     Document Type: Review

References (170)

1. G.E. Adams I.J. Stratfore J. Godden Enhancement of the anti-tumor effect of melphalan in experimental mice by some vaso-active agents Int J Radiat Oncol Biol Plays 16 1989 1137 1139
2. G.W. Barendsen J.J. Broerse Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV x-rays. I. Effects of single exposures Eur J Cancer 5 1969 373 391
3. S.C. Barranco J.K. Novak Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or Adriamycin Cancer Res 34 1974 1616 1618
4. S.C. Barranco J.K. Novak R.M. Humphrey Response of mammalian cells following treatment with bleomycin and 1, 3-bis(2-chloroethyl)-1-nitrosourea during plateau phase Cancer Res 33 1973 691 694
5. C.A. Belfi L.-L. Ting S.J. Hassenbusch Determination of changes in tumor blood perfusion after hydralazine treatment by dynamic paramagnetic-enhanced magnetic resonsance imaging Int J Radiat Oncol Biol Phys 22 1992 477 482
6. B.K. Bhuyan T.J. Fraser K.J. Day Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells Cancer Res 37 1977 1057 1063
7. R. Born O. Hug K.R. Trott The effect of prolonged hypoxia on growth and viability of Chinese hamster ovary cells Int J Radiat Oncol Biol Phys 1 1976 687 697
8. P.M. Breepel F. Kreuzer M. Hazevoet Interactions of organic phosphates with bovine hemoglob Oxylabile F I. phosphate-labile proton binding Pflugers Arch 389 1981 219
9. H.F. Bunn Differences in the interaction of 2,3-diphosphoglycerate with certain mammalian hemoglobins Science 172 1971 1049 1050
10. R.S. Bush R.D.T. Jenkin W.E.C. Alit Definitive evidence for hypoxic cells influencing cure in chemotherapy Br J Cancer 37 Suppl III 1978 302 306
11. D.B. Cater I.A. Silver Quantitative measurements of oxygen tension in normal tissues and in the tumours of patients before and after radiotherapy Acta Radiol 53 1960 23 256
12. T.M.S. Chang Attempts to find a method to prepare artificial hemoglobin corpuscles Biomater Artif Cells Artif Organs 16 1988 1 11
13. T.M.S. Chang Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: An overview Biomaterial Artificial Cells Immobilization Biotechnology 20 2–4 1992 159 179
14. T.M.S. Chang Red blood cell substitutes: Microencapsulated hemoglobin and cross- linked hemoglobin including pyridoxylated polyhemoglobin and conjugated hemoglobin Biomat Art Cells Immobiol Biotech 16 1988 11 29
15. D.J. Chaplin Hydralazine-induced tumor hypoxia: A potential target for cancer chemotherapy J Natl Cancer Inst 81 1989 618 622
16. D.J. Chaplin B. Acker P.L. Olive Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs Int J Radiat Oncol Biol Phys 16 1989 1131 1135
17. D.J. Chaplin M.R. Horsman Tumor blood flow changes induced by chemical modifiers of radiation response Int J Radiat Oncol Biol Phys 22 1992 459 462
18. D.J. Chaplin M.R. Horsman M.J. Trotter The effect of nicotinamide on microregional heterogeneity of oxygen delivery within a murine tumor J Natl Cancer Inst 82 1990 672 676
19. A. Cochen T.K. Das Gupta R. DeWoskin Immunologic properties of stroma vs. stroma-free hemoglobin solution J Surg Oncol 4 1974 19
20. P.G. Cunnington S.N. Jenkins S.C. Tam Oxygen-binding and immunological properties of complexes between dextran and animal hemoglobins Biochem J 193 1981 261 266
21. M.W. Dewhirst Angiogenesis and blood flow BA Teicher Drug Resistance in Oncology 1993 Marcel Dekker New York 3 24
22. M.W. Dewhirst E.T. Ong D. Jadwed Effects of the calcium channel blocker flunarizine on tumor microvascular hemodynamics and oxygenation Radiat Res 132 1992 61 68
23. M.W. Dewhirst D.M. Prescott S. Clegg The use of hydralazine to manipulate tumour temperatures during hyperthermia Int J Hyperthermia 6 1990 971 983
24. W. Duncan Exploitation of the oxygen enhancement ratio in clinical practice Br Med Bull 29 1973 33
25. R.G. Evans B.F. Kinder R.A. Morantz Lack of complications in long-term survivors after treatment with Fluosol® and oxygen as an adjuvant to radiation therapy for high-grade brain tumors Int J Radiat Oncol Biol Phys 26 1993 649 652
26. R.G. Evans B.F. Kimler R.A. Morantz A Phase I/II study of the use of Fluosol®-DA 20% as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors Int J Radiat Oncol Biol Phys 19 1990 415 420
27. B.M. Fenton R.M. Sutherland Effect of flunarizine on micro-regional distributions of intravascular HbO2 saturations in RIF-1 and KHT sarcomas Int J Radiat Oncol Biol Phys 22 1992 447 450
28. W. Fleckenstein Distribution of oxygen pressure in the periphery and centre of malignant head and neck tumours 1990 Blackwell Ueberreuter Wissenchaft Berlin k81 k90
29. R.E. Forster Carbon monoxide and the partial pressure of oxygen in tissue Ann NJ Acad Sci 174 1970 233 241
30. J.F. Fowler R.L. Morgan C.A.P. Wood Pre-therapeutic experiments with the fast neutron beam from the medical research council cyclotron Brit J Radiol 36 1963 77 80
31. J.R. Fowler R.H. Thomlinson A.E. Howes Time-dose relationships in radiotherapy Eur J Canger 6 1970 207
32. P. Gaehtgens P. Kreutz K.H. Albrecht Optimal hematocrit for canine skeletal muscle during rhythmic isotomic exercise Eur J Appl Physiol 41 1979 27 39
33. R.A. Gatenby L.R. Coia M.P. Richter Oxygen tension in human tumours: In vivo mapping using CT-guided probes Radiology 156 1985 211 214
34. R.A. Gatenby H.B. Kessler J.S. Rosenblum Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of therapy Int J Radiat Oncol Biol Phys 14 1988 831 838
35. A.G. Gilman T.W. Rail A.S. Nies The Pharmacological Basis of Therapeutics ed 8 1990 Pergamon Press New York
36. P.M. Gullino In vivo utilization of oxygen and glucose by neoplastic tissue Adv Exp Med Biol 75 1975 521 536
37. G.M. Hahn E.C. Shiu Adaptation to low pH modifies thermal and thermochemical responses of mammalian cells Int J Hyperthermia 2 1986 379 387
38. E.J. Hall Radiobiology for the Radiobiologist ed 2 1978 Harper & Row Philadelphia 235 243
39. D.F.J. Halmagyi A.H. Goodman Vascular resistance and oxygen transport as functions of haematocrit Resuscitation 3 1974 165 170
40. T. Hasegawa J.G. Rhee S.H. Levitt Increase in tumor pO2 by perfluorochemicals and carbogen Int J Radiat Oncol Biol Phys 13 1987 569 574
41. J.M. Henk P.B. Kinkier C.W. Smith Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial Lancet 2 1977 101 103
42. T.S. Herman B.A. Teicher L.S. Collins Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures Cancer Res 48 1988 2342 2347
43. T.S. Herman B.A. Teicher S.A. Holden Interaction of hyperthermia and radiation: Hypoxia and acidosis in vitro , tumor subpopulations in vivo Cancer Res 49 1989 3338 3343
44. T.S. Herman B.A. Teicher M. Jochelson Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies Int J Hyperthermia 4 1988 143 158
45. H.B. Hewitt E. Blake Effect of induced host anemia on the viability and radiosensitivity of murine malignant cells in vivo Br J Cancer 25 1971 323 336
46. R.P. Hill D. Stirling Oxygen delivery and tumour response M Fielden JF Fowler JH Hendry Scott The 8th International Congress of Radiation Research 1987 Taylor and Francis London
47. R.P. Hill R.S. Bush P. Yeung The effect of anemia on the fraction of hypoxic cells in an experimental tumour Br J Radiol 44 1971 299 304
48. D.C. Hirst Oxygen delivery to tumors Int J. Radiat Oncol Biol Phys 180 1986 281 291
49. D.G. Hirst P.J. Wood The influence of haemoglobin affinity for oxygen on tumour radiosensitivity Br J Cancer 55 1987 487 491
50. D.G. Hirst J.L. Hazlehurst J.M. Brown The effect of hematocrit on tumour sensitivity to X-rays Int J Radiat Biol 46 1984 345 354
51. D.G. Hirst P.J. Wood H.C. Schwartz The modification of tumor radiosensitivity by antilipidemic drags Radiat Res 112 1987 164 172
52. M. Höckel K. Schienger C. Knoop Oxygenation of carcinomas of the uterine cervix: evaluation by computerized 02 tension measurements Cancer Res 51 1991 6098 6102
53. S.A. Holden T.S. Herman B.A. Teicher Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA®/carbogen/radiation Radiother Oncol 18 1990 59 70
54. M.R. Horsman D.M. Brown D.G. Hirst Changes in the response of the RIF-1 tumor to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase Br J Cancer 53 1986 247 254
55. M.R. Horsman D.J. Chaplin J.M. Brown Tumor radiosensitization by nicotinamide: A result of improved perfusion and oxygenation Radiat Res 118 1989 139 150
56. M.R. Horsman K.L. Christensen J. Overgaard Relationship between the hydralazine- induced changes in murine tumor blood supply and mouse blood pressure Int J Radiat Oncol Biol Phys 22 1992 455 458
57. A.E. Howes An estimation of changes in the proportions and absolute numbers of hypoxic cells after irradiation of transplanted C3H mouse mammary tumours Br J Radiol 42 1969 441 447
58. L.J. Ignarro J.C. Edwards D.Y. Gruetter Possible involvement of S-nitrothiols in the activation of guanylate cyclase by nitroso compounds Federation of Europaean Biochemical Societies Letters 110 1980 275 278
59. R.K. Jain Determinants of tumor blood flow: A review Cancer Res 48 1988 2641 2658
60. C. Jung W. Muller-Klieser P. Vaupel Tumor blood flow and 02 availability during hemodilution Adv Exp Med Biol 180 1984 281 291
61. W.G.J. Kaelin S. Shrivastav R.L. Jirtle Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine Cancer Res 44 1984 896 899
62. W.G.J. Kaelin S. Shrivastav D.G. Shand Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats Cancer Res 42 1982 3944 3949
63. F. Kallinowski P. Vaupel pH distributions in spontaneous and isotransplanted rat tumours Br J Cancer 58 1988 134 321
64. F. Kallinowski R. Zander M. Höckel Tumor tissue oxygenation as evaluated by computerized-pO2-histography Int J Radiat Oncol Biol Phys 19 1990 953 961
65. R.F. Kallman The phenomenon of reoxygenation and its implications for fractionated radiotherapy Radiology 105 1972 135 142
66. R.F. Kallman S. Rockwell F.F. Becker Cancer 1977 Plenum Press New York 225 279
67. J. Kalmus P. Okunieff P. Vaupel Dose-dependent effects of hydralazine on microcircu- latory function and hyperthermic response of murine FSall tumors Cancer Res 50 1990 15 19
68. K.A. Kennedy B.A. Teicher S.A. Rockwell The hypoxic tumor cell: A target for selective cancer chemotherapy Biochem Pharmacol 29 1980 18
69. S.R. Keyes S. Rockwell A.C. Sartorelli Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro Cancer Res 45 1985 3642 3645
70. G.E. Kim C.W. Song The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo Cancer Chemother Pharmacol 25 1989 99 102
71. T. Kokunai K. Kuwamura Effect of perfluorochemicals on BCNU chemotherapy: Preliminary study in a rat brain tumor model Surg Neurol 18 1982 258 261
72. P. Kolstad Intercapillary distance, oxygen tension and local recurrence in cervix cancer Scand J Clin Lab Invest 106 1968 145 157 (Suppl)
73. T. Kuroiwa K. Aoki S. Toniguchi Efficacy of two route chemotherapy using cis- diamrninedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor Cancer Res 47 1987 3618 3623
74. K. Kuwamura T. Kokunai N. Tamaki Synergistic effect of perfluorochemicals on BCNU chemotherapy: Experimental study in a 9L rat brain-tumor model J Neurosurg 57 1982 467 471
75. E. Lartigau A.-M. Le Ridant P. Lambin Oxygenation of head and neck tumors Cancer 71 1993 2319 2325
76. M.D. Laver E. Jackson M. Scherperel Hemoglobin-02 affinity regulation: DPF, monovalent ions, and hemoglobin concentration J Appl Physiol 43 1977 632
77. I. Lee J.H. Kim S.H. Levitt Increases in tumor response by pentoxifylline alone or in combination with nicotinamide Int J Radiat Oncol Biol Phys 22 1992 425 429
78. I. Lee S.H. Levitt C.W. Song Effects of Fluosol-DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice Radiat Res 112 1987 173 182
79. I. Lee S.H. Levitt C.W. Song Radiosensitization of murine tumors by Fluosol-DA 20% Radiat Res 122 1990 275 279
80. R. Lustig N. Lowe L. Prosnitz Fluosol and oxygen breathing as an adjuvant to radiation therapy in the treatment of locally advanced non-small cell carcinoma of the lung: Results of a phase I/II study Int J Radiat Oncol Biol Phys 19 1990 97 102
81. R. Lustig N.L. Mclntosh-Lowe C. Rose Phase I/II study of Fluosol-DA and 100% oxygen breathing as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck Int J Radiat Oncol Biol Phys 16 1989 1587 1594
82. D.F. Martin B.F. Kinder R.G. Evans Potentiation of rat brain tumor therapy by Fluosol and carbogen NCI Monographs 6 1988 119 122
83. D.F. Martin E.A. Porter J.J. Fischer Effect of a perfluorochemical emulsion on the radiation response of BA-1112 rhabdomyosarcomas Radiat Res 112 1987 45 53
84. L. Martin E. Lartigau P. Weeger Changes in the oxygenation of head and neck tumors during carbogen breathing Radiat Ther Oncol 27 1993 123 130
85. R.L. Momparler In vitro systems for evaluation of combination chemotherapy Pharmacol Ther 8(A) 1980 21 35
86. J.C. Mottram A. Eidinow On the effect of anaemia on the reactions of skin and of tumors to radium exposure Br J Surg 19 1932 481 487
87. J.E. Moulder B.L. Fish Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation Int J Radiat Oncol Biol Phys 15 1988 1193 1196
88. J.E. Moulder J. Dutreix S. Rockwell Applicability of animal tumor data to cancer therapy in humans Int J Radiat Oncol Biol Phys 14 1988 913 927
89. J.E. Moulder J.J. Fischer R. Milardo Time-dose relationships for the cure of an experimental rat tumor with fractionated radiation Int J Radiat Oncol Biol Phys 1 1976 431 438
90. P. Okunieff M. Hoeckel E.P. Dunphy Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone Int J Radiat Oncol Biol Phys 26 1993 631 636
91. P. Okunieff F. Kallinowski P. Vaupel Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31 P-nuclear magnetic resonance spectroscopy J Natl Cancer Inst 80 1988 745 750
92. P. Okunieff C.S. Walsh P. Vaupel Effects of hydralazine on in vivo tumor energy metabolism, hematopoietic radiation sensitivity, and cardiovascular parameters Int J Radiat Oncol Biol Phys 16 1989 1145 1148
93. C.E. Peters D.J. Chaplin Blood flow modification in the SCCVII tumor: Effects of 5-hydroxytryptamine, hydralazine, and propranolol Int J Radiat Oncol Biol Phys 22 1992 463 465
94. W.E. Powers L.J. Tolmach A multicomponent x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo Nature 197 1963 710 711
95. D.M. Prescott T.V. Samulski M.W. Dewhirst Use of nitroprusside to increase tissue temperature during local hyperthermia in normal and tumor-bearing dogs Int J Radiat Oncol Biol Phys 23 1992 377 385
96. S. Rapoport G.M. Guest Distribution of acid-soluble phosphorous in the blood cells of various vertebrates J Biol Chem 138 1941 269 280
97. H.S. Reinhold C. De Bree Tumour cure rate and cell survival of a transplantable rat rhabdomyosarcoma following x-irradiation Eur J Cancer 4 1968 367 374
98. S. Rockwell R.F. Kallman Cellular radiosensitivity and tumor radiation response in the EMT-6 tumor cell system Radiat Res 53 1973 281 294
99. S. Rockwell T.P. Mato C.G. Irvin Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion Int J Radiat Oncol Biol Phys 12 1986 1315 1318
100. C.M. Rose R. Lustig N. McIntosh A clinical trial of Fluosol-DA 20% in advanced squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 12 1986 1325 1327
101. A.C. Sartorelli Therapeutic attack of hypoxic cells of solid tumors: Presidential address Cancer Res 48 1988 775
102. K.H. Schienger M. Hoeckel P. Vaupel Detection of radiobiological hypoxia in cancers of the cervix and the breast: Evaluation by computerized O, tension measurements in patients 1991 Geneva Park Canada
103. U. Schramm W. Fleckenstein C. Weber Morphological assessment of skeletal muscular injury caused by p02 measurements with hypodemic needle probes A.M. Ehrly W. Fleckenstein J. Hauss R. Huch Clinial Oxygen Pressure Measurement 1990 Blackwell Ueberreuter Wissenschaft Berlin 38 50
104. E.M. Sevick R.K. Jain Geometric resistance to blood flow in solid tumors perfused ex vivo: Effects of tumor size and perfusion pressure Cancer Res 49 1989 3513 3519
105. D.W. Siemann P.C. Keng Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (ii) Cell sorting Br J Cancer 58 1988 296 300
106. D.W. Siemann L.M. Macier Tumor radiosensitization through reductions in hemoglobin affinity Int J Radiat Oncol Biol Phys 12 1986 1295 1297
107. D.W. Siemann M.J. Bronskill R.P. Hill The relationship between mouse arterial partial pressure of oxygen (Pao2) and the effectiveness of localized tumour irradiation Br J Radiol 48 1975 662 667
108. D.W. Siemann R.P. Hill R.S. Bush Smoking: The influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to radiation Int J Radiat Oncol Biol Phys 4 1978 657 662
109. D.W. Siemann R.P. Hill R.S. Bush The in vivo radiation response of an experimental tumor: The effect of exposing tumor-bearing mice to reduced oxygen environment prior to but not during irradiation Int J Radiat Oncol Biol Phys 5 1979 61 68
110. G. Singbartl G. Metzger G. Beister Investigation on the reproducibility of intramuscular pO2 measurement in patients by means of the tissue pO2-Histograph Kimoc/Sigma A.M. Ehrly W. Fleckenstein J. Hauss R. Huch Clinical Oxygen Pressure Measurement 1990 Blackwell Ueberreuter Wissenschaft Berlin 25 29
111. R.P. Smith H. Kruszyna Nitroprusside produces cyanide poisoning via a reaction with hemoglobin J Pharmacol Exp Ther 191 1974 557 563
112. C.W. Song I. Lee T. Hasegawa Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen Cancer Res 47 1987 442 446
113. I.J. Stratford G.E. Adams J. Godden Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine Br J Cancer 58 1988 122 127
114. H.D. Suit M. Maeda Hyperbaric oxygen and radiobiology of the C3H mouse mammary carcinoma J Natl Cancer Inst 39 1967 639 652
115. H.D. Suit R.J. Shalek Response of anoxic C3H mouse mammary carcinoma isotransplants (1-25 mm3) to x irradiation J Natl Cancer Inst 31 1963 479 493
116. H.D. Suit C. Suchato Hyperbaric oxygen and radiotherapy of a fibrosarcoma and of squamous-cell carcinoma of C3H mice Radiology 89 1967 713 719
117. H.D. Suit R.S. Sedlacek G. Silver Pentobarbital anesthesia and the response of tumor and normal tissue in the C3Hf/sed mouse to radiation Radiat Res 104 1985 47 65
118. M. Suzuki K. Hori I. Abe A new approach to cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin II J Natl Cancer Inst 67 1981 663 669
119. B.A. Teicher T.S. Herman Use of fluosol-DA/oxygen breathing with radiation therapy and chemotherapy/radiation combinations M.J. John M.S. Flam S.S. Legha T.L. Phillips Chemoradiation: An Integrated Approach to Cancer Treatment 1993 Lea & Febiger Philadelphia 140 158
120. B.A. Teicher S.A. Holden Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents Cancer Treatment Reports 71 1987 173 177
121. B.A. Teicher C.M. Rose Effect of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion Fluosol-DA. Int J Radiat Oncol Biol Phys 12 1986 1311 1313
122. B.A. Teicher C.M. Rose Oxygen-carrying perfluorochemical emulsion as an adjuvant to radiation therapy in mice Cancer Res 44 1984 4285 4288
123. B.A. Teicher C.M. Rose Perfluorochemical emulsion can increase tumor radiosensitivity Science 223 1984 934 936
124. B.A. Teicher S.D. Bernal S.A. Holden Effect of Fluosol-DA/carbogen on etopo- side/alkylating agent antitumor activity Cancer Chemother Pharmacol 21 1988 281 285
125. B.A. Teicher J.M. Crawford S.A. Holden Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity Cancer Res 47 1987 5036 5041
126. B.A. Teicher N.P. Dupuis M.F. Robinson Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing J Cancer Res Clin Oncol 120 1994 593 598
127. B.A. Teicher T.S. Herman E. Frei III Perfluorochemical emulsions: Oxygen breathing in radiation sensitization and chemotherapy modulation V.T.J. DeVita S. Heilman S.A. Rosenberg Important Advances in Oncology 1992 JB Lippincott Philadelphia 39 59
128. B.A. Teicher T.S. Herman S.A. Holden The effect of Fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo Cancer Chemother Pharmacol 21 1988 286 291
129. B.A. Teicher T.S. Herman R.E. Hopkins Effect of a bovine hemoglobin preparation on the response of the FSallC fibrosarcoma to chemotherapeutic alkylating agents J Cancer Res Clin Oncol 118 1992 123 128
130. B.A. Teicher T.S. Herman S.M. Jones Influence of scheduling, dose, and volume of administration of perfluorochemical emulsion on tumor response to radiation therapy Int J Radiat Oncol Biol Phys 19 1991 945 951
131. B.A. Teicher T.S. Herman S.M. Jones Optimization of perfluorochemical levels with radiation therapy in mice Cancer Res 49 1989 2693 2697
132. B.A. Teicher T.S. Herman C.M. Rose Effect of Fluosol-DA® on the response of intracranial 9L tumors to x-rays and BCNU Int J Radiat Oncol Biol Phys 15 1988 1187 1192
133. B.A. Teicher S.A. Holden A. Al-Achi Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in FSallC murine fibrosarcoma Cancer Res 50 1990 3339 3344
134. B.A. Teicher S.A. Holden G. Ara Effect of a bovine hemoglobin preparation (SBHS) on the response of two murine solid tumors to radiation therapy or chemotherapeutic alkylating agents Biomat Art Cells Immobiol Biotech 20 1992 657 660 (2–4)
135. B.A. Teicher S.A. Holden J.M. Crawford Effects of Fluosol®-DA and oxygen breathing on Adriamycin antitumor activity and cardiac toxicity in mice Cancer 61 1988 2196 2201
136. Teicher BA, Holden SA, Dupuis NP, et al: Oxygenation of the rat 9L gliosarcoma and the rat 13672 mammary carcinoma with various doses of a hemoglobin solution. Biomat Art Cells Immobiol Biotech, in press.
137. B.A. Teicher S.A. Holden J.L. Jacobs Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity Cancer Res 47 1987 513 518
138. Teicher BA, Holden SA, Menon K, et al: Effect of a hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents. Cancer Chemother Pharmacol, in press.
139. B.A. Teicher S.A. Holden D. Northey Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside Int J Radiat Oncol Biol Phys 26 1993 103 109
140. B.A. Teicher S.A. Holden C.M. Rose Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing Int J Cancer 36 1985 585 589
141. B.A. Teicher S.A. Holden C.M. Rose Effect of Fluosol-DA/O2 on tumor cell and bone marrow cytotoxicity of nitrosoureas in mice bearing FSall fibrosarcoma Int J Cancer 38 1986 285 288
142. B.A. Teicher S.A. Holden C.M. Rose Effect of oxygen on the cytotoxicity and antitumor activity of etoposide J Natl Cancer Inst 75 1985 1129 1133
143. B.A. Teicher J.S. Lazo W.W. Merrill Effect of Fluosol-DA/02 on the antitumor activity and pulmonary toxicity of bleomycin Cancer Chemother Pharmacol 18 1986 213 218
144. B.A. Teicher J.S. Lazo A.C. Sartorelli Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells Cancer Res 41 1981 73 81
145. B.A. Teicher N.L. Mclntosh-Lowe C.M. Rose Effect of various oxygenation conditions and Fluosol-DA on cancer chemotherapeutic agents Biomat Art Cells Immobiol Biotech 16 1988 533 546
146. B.A. Teicher G.N. Schwartz E. Alvarez Sotomayor Oxygenation of tumors by a hemoglobin solution J Cancer Res Clin Oncol 120 1993 85 90
147. Teicher BA, Schwartz GN, Dupuis NP, et al: Oxygenation of human tumor xenografts in nude mice by a perfluorochemical emulsion and carbogen breathing. Biomat Art Cells Immobiol Biotech, in press.
148. B.A. Teicher E.A. Sotomayor M.F. Robinson Tumor oxygenation and radiosensitization by pentoxifylline and a perflubron emulsion/carbogen breathing Int J Oncol 2 1993 13 21
149. B.A. Teicher D.J. Waxman S.A. Holden Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N, N′ N″- triethylenethi- ophosphoramide Cancer Res 49 1989 4996 5001
150. C. Thomas C. Counsell P. Wood Use of fluorine-19 nuclear magnetic resonsance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice J Natl Cancer Inst 84 1992 174 180
151. R.H. Thomlinson Conference on time and dose relationships in radiation biology as applied to radiotherapy 1970 Brookhaven Natl Lab Rep Springfield, VA 242 247
152. R.H. Thomlinson E.A. Craddock The gross response of an experimental tumour to single doses of x-ray Br J Cancer 21 1967 108 123
153. M.J. Trotter D.J. Chaplin P.L. Olive The effect of angiotensin II on intermittent tumour blood flow and acute hypoxia in the murine SCVH carcinoma Eur J Cancer 27 1991 887 893
154. P.R. Twentyman Comparative chemosensitivity of exponential versus plateau-phase cells in both in vitro and in vivo model systems Cancer Treatment Reports 60 1976 1719 1722
155. L.M. Van Putten Tumor reoxygenation during fractionated radiotherapy: Studies with a transplantable mouse osteosarcoma Eur J Cancer 4 1968 173 182
156. L.M. Van Putten R.F. Kallman Oxygenation status of a transplantable tumor during fractionated radiation therapy J Natl Cancer Inst 40 1968 441 451
157. P. Vaupel Hypoxia and neoplastic tissue Microvasc Res 13 1977 399 408
158. P. Vaupel Oxygenation of human tumors Strahlenther Onkol 166 1990 377 386
159. P. Vaupel Oxygenation of solid tumors B.A. Teicher Drug Resistance in Oncology 1993 Marcel-Dekker New York 53 85
160. P. Vaupel H. Menke Blood flow, vascular resistance and oxygen availability in malignant tumours upon intravenous flunarizine Adv Exp Med Biol 215 1987 393 398
161. P. Vaupel H. Menke Effect of various calcium antagonists on blood flow and red blood cell flux in malignant tumors Progress in Applied Microcirculation 14 1989 88 103
162. P. Vaupel H.P. Fortmeyer S. Runkel Blood flow, oxygen consumption and tissue oxygenation of human breast cancer xenografts in nude rats Cancer Res 47 1987 3496 3503
163. P. Vaupel S. Frinak H.I. Bicher Heterogeneous oxygen partial pressure and pH distribution C3H mouse mammary adenocarcinoma Cancer Res 41 1981 2008 2013
164. P. Vaupel F. Kallinowski P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review Cancer Res 49 1989 6449 6465
165. P. Vaupel P. Okunieff F. Kallinowski Correlations between 31p-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma Radiat Res 120 1989 477 493
166. P. Vaupel K. Schienger M. Hoeckel Blood flow and tissue oxygenation of human tumors: An update Adv Exp Med Biol 316 1992 361 371
167. P. Vaupel K. Schienger C. Knoop Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancer by computerized O2 tension measurements Cancer Res 51 1991 3316 3322
168. L. Vitu-Loas C. Thomas N. Chavaudra Radiosensitivity, blood perfusion and tumour oxygenation after perflubron emulsion injection Radiother Oncol 27 1993 149 155
169. P.J. Wood D.G. Hirst Calcium antagonists as radiation modifiers: Site specificity in relation to tumor response Int J Radiat Oncol Biol Phys 16 1989 1141 1144
170. P.J. Wood D.G. Hirst Cinnarizine and flunarizine as radiation sensitizers in two murine tumours Br J Cancer 58 1989 742 745